Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 64

1.

[Implementation Evaluation of the Pare-Chocs Program in High School].

Poirier M, Marcotte D, Joly J, Fortin L.

Sante Ment Que. 2017 Spring;42(1):355-377. French.

PMID:
28792577
2.

[Efficacy of mental health prevention and promotion strategies in higher education].

Martineau M, Beauchamp G, Marcotte D.

Sante Ment Que. 2017 Spring;42(1):165-182. French.

PMID:
28792567
3.

Can weight predict academic performance in college students? An analysis of college women's self-efficacy, absenteeism, and depressive symptoms as mediators.

Aimé A, Villatte A, Cyr C, Marcotte D.

J Am Coll Health. 2017 Apr;65(3):168-176. doi: 10.1080/07448481.2016.1266639. Epub 2016 Dec 2.

PMID:
27911679
4.

ATP-Competitive MLKL Binders Have No Functional Impact on Necroptosis.

Ma B, Marcotte D, Paramasivam M, Michelsen K, Wang T, Bertolotti-Ciarlet A, Jones JH, Moree B, Butko M, Salafsky J, Sun X, McKee T, Silvian LF.

PLoS One. 2016 Nov 10;11(11):e0165983. doi: 10.1371/journal.pone.0165983. eCollection 2016.

5.

Germinal-center kinase-like kinase co-crystal structure reveals a swapped activation loop and C-terminal extension.

Marcotte D, Rushe M, M Arduini R, Lukacs C, Atkins K, Sun X, Little K, Cullivan M, Paramasivam M, Patterson TA, Hesson T, D McKee T, May-Dracka TL, Xin Z, Bertolotti-Ciarlet A, Bhisetti GR, Lyssikatos JP, Silvian LF.

Protein Sci. 2017 Feb;26(2):152-162. doi: 10.1002/pro.3062. Epub 2016 Oct 21.

PMID:
27727493
6.

Structural determinant for inducing RORgamma specific inverse agonism triggered by a synthetic benzoxazinone ligand.

Marcotte DJ, Liu Y, Little K, Jones JH, Powell NA, Wildes CP, Silvian LF, Chodaparambil JV.

BMC Struct Biol. 2016 Jun 1;16(1):7. doi: 10.1186/s12900-016-0059-3.

7.

Discovery of biaryls as RORγ inverse agonists by using structure-based design.

Enyedy IJ, Powell NA, Caravella J, van Vloten K, Chao J, Banerjee D, Marcotte D, Silvian L, McKenzie A, Hong VS, Fontenot JD.

Bioorg Med Chem Lett. 2016 May 15;26(10):2459-63. doi: 10.1016/j.bmcl.2016.03.109. Epub 2016 Apr 1.

PMID:
27080181
8.

Discovery of biaryl carboxylamides as potent RORγ inverse agonists.

Chao J, Enyedy I, Van Vloten K, Marcotte D, Guertin K, Hutchings R, Powell N, Jones H, Bohnert T, Peng CC, Silvian L, Hong VS, Little K, Banerjee D, Peng L, Taveras A, Viney JL, Fontenot J.

Bioorg Med Chem Lett. 2015 Aug 1;25(15):2991-7. doi: 10.1016/j.bmcl.2015.05.026. Epub 2015 May 23.

PMID:
26048806
9.

Discovery of novel pyrazole-containing benzamides as potent RORγ inverse agonists.

Wang T, Banerjee D, Bohnert T, Chao J, Enyedy I, Fontenot J, Guertin K, Jones H, Lin EY, Marcotte D, Talreja T, Van Vloten K.

Bioorg Med Chem Lett. 2015 Aug 1;25(15):2985-90. doi: 10.1016/j.bmcl.2015.05.028. Epub 2015 May 22.

PMID:
26048789
10.

Allergy test: Seasonal allergens and performance in school.

Marcotte DE.

J Health Econ. 2015 Mar;40:132-40. doi: 10.1016/j.jhealeco.2015.01.002. Epub 2015 Jan 16.

PMID:
25680109
11.

Structure-based design of low-nanomolar PIM kinase inhibitors.

Ishchenko A, Zhang L, Le Brazidec JY, Fan J, Chong JH, Hingway A, Raditsis A, Singh L, Elenbaas B, Hong VS, Marcotte D, Silvian L, Enyedy I, Chao J.

Bioorg Med Chem Lett. 2015 Feb 1;25(3):474-80. doi: 10.1016/j.bmcl.2014.12.041. Epub 2014 Dec 19.

PMID:
25575657
12.

Tricyclic covalent inhibitors selectively target Jak3 through an active site thiol.

Goedken ER, Argiriadi MA, Banach DL, Fiamengo BA, Foley SE, Frank KE, George JS, Harris CM, Hobson AD, Ihle DC, Marcotte D, Merta PJ, Michalak ME, Murdock SE, Tomlinson MJ, Voss JW.

J Biol Chem. 2015 Feb 20;290(8):4573-89. doi: 10.1074/jbc.M114.595181. Epub 2014 Dec 31.

13.

Achieving cultural congruency in weight loss interventions: can a spirituality-based program attract and retain an inner-city community sample?

Davis C, Dutton WB, Durant T, Annunziato RA, Marcotte D.

J Obes. 2014;2014:641939. doi: 10.1155/2014/641939. Epub 2014 Apr 7.

14.

Patterns of substance use among HIV-positive adults over 50: implications for treatment and medication adherence.

Parsons JT, Starks TJ, Millar BM, Boonrai K, Marcotte D.

Drug Alcohol Depend. 2014 Jun 1;139:33-40. doi: 10.1016/j.drugalcdep.2014.02.704. Epub 2014 Mar 19.

15.
16.

[The trajectory of depressive symptoms from childhood to adolescence and targets for preventive intervention].

Marcotte D, Lemieux A.

Cien Saude Colet. 2014 Mar;19(3):785-96. French. No abstract available.

17.

Small molecules inhibit the interaction of Nrf2 and the Keap1 Kelch domain through a non-covalent mechanism.

Marcotte D, Zeng W, Hus JC, McKenzie A, Hession C, Jin P, Bergeron C, Lugovskoy A, Enyedy I, Cuervo H, Wang D, Atmanene C, Roecklin D, Vecchi M, Vivat V, Kraemer J, Winkler D, Hong V, Chao J, Lukashev M, Silvian L.

Bioorg Med Chem. 2013 Jul 15;21(14):4011-9. doi: 10.1016/j.bmc.2013.04.019. Epub 2013 Apr 19.

PMID:
23647822
18.

Enabling structure-based drug design of Tyk2 through co-crystallization with a stabilizing aminoindazole inhibitor.

Argiriadi MA, Goedken ER, Banach D, Borhani DW, Burchat A, Dixon RW, Marcotte D, Overmeyer G, Pivorunas V, Sadhukhan R, Sousa S, Moore NS, Tomlinson M, Voss J, Wang L, Wishart N, Woller K, Talanian RV.

BMC Struct Biol. 2012 Sep 20;12:22. doi: 10.1186/1472-6807-12-22.

19.

Structure-based design of 2,6,7-trisubstituted-7H-pyrrolo[2,3-d]pyrimidines as Aurora kinases inhibitors.

Le Brazidec JY, Pasis A, Tam B, Boykin C, Wang D, Marcotte DJ, Claassen G, Chong JH, Chao J, Fan J, Nguyen K, Silvian L, Ling L, Zhang L, Choi M, Teng M, Pathan N, Zhao S, Li T, Taveras A.

Bioorg Med Chem Lett. 2012 Jun 15;22(12):4033-7. doi: 10.1016/j.bmcl.2012.04.085. Epub 2012 Apr 25.

PMID:
22607669
20.

An inactivating caspase 11 passenger mutation originating from the 129 murine strain in mice targeted for c-IAP1.

Kenneth NS, Younger JM, Hughes ED, Marcotte D, Barker PA, Saunders TL, Duckett CS.

Biochem J. 2012 Apr 15;443(2):355-9. doi: 10.1042/BJ20120249.

Supplemental Content

Loading ...
Support Center